NimbleRx

About

Nimble provides a pharmacy experience centered around the patient's needs to provide a more streamlined workflow.

Redwood City,California,United States
51 - 100
https://www.nimblerx.com/

Highlights

Details

Last Funding Type: Series Unknown
Industries: Health Care,Medical,Mobile,Pharmaceutical
Founded date: Jan 1, 2015
Number Of Employee: 51 - 100
Operating Status: Active
Legal Name: Nimble Rx, Inc.
Also Known As: Nimble Pharmacy,Nimble Rx,Nimble

Provider of on demand drug delivery platform intended to create a better experience for patients at a lower price. Nimble partners with pharmacies nationwide to provide prescription delivery, as well as a mobile app for patients to manage and review prescriptions/orders from their phone.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

6

$74.86M

NimbleRx has raised a total of $74.86M in funding over 2 rounds. Their latest funding was raised on Jun 13, 2022 from a Series Unknown round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jun 13, 2022	Series Unknown	$14.74M	—	—	—	Detail
Apr 3, 2018	Series C	$20M	1	Four Rivers Group	—	Detail
Oct 24, 2017	Series B	$28M	5	Sequoia Capital	—	Detail
Mar 23, 2017	Series Unknown	—	1	—	—	Detail
Oct 13, 2015	Series A	$12M	5	Sequoia Capital	—	Detail

Investments

Number of Investments

Number of Lead Investments

1

0

NimbleRx has made 1 investments. Their most recent investment was on Nov 1, 2015, when Carv raised $20K.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Nov 1, 2015 Carv	Funding Round	$20K	Consumer Electronics	—

Investors

Number of Lead Investors

Number of Investors

3

9

NimbleRx is funded by 9 investors. Four Rivers Group and Sequoia Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
Four Rivers Group	Yes	Series C
Sequoia Capital	Yes	Series B
DAG Ventures	—	Series B
First Round Capital	—	Series B
Khosla Ventures	—	Series B
Y Combinator	—	Series B
Naver	—	Series Unknown
Felicis Ventures	—	Series A
SVA	—	Series A